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Abstract
Objectives We tested three hypotheses: (1) blacks with pancreatic cancer are recommended surgical resection less often than
whites; (2) when recommended surgical resection, blacks refuse surgery more often than whites; and lastly, (3) racial differences
in refusal of surgical resection have decreased over time.
Methods A retrospective cohort study was conducted on patients with potentially resectable, nonmetastatic pancreatic adeno-
carcinoma of the Surveillance, Epidemiology, and End Results registry from 1988 to 2009. Univariate and multivariable logistic
regression analyses were performed to assess whether differences in the proportion of whites versus blacks refusing surgery
among patients recommended for resection changed over time.
Results A total of 35,944 patients were included; most were white (87.6 %). After adjusting for covariates including tumor stage,
pancreatic cancer resection was less often recommended to and performed in blacks compared with whites (adjusted odds ratio (aOR)
0.88, 95% confidence interval (CI) 0.82–0.95; aOR 0.83, 95%CI 0.76–0.91, respectively). Blacks also underwent surgical resection
less often when surgery was recommended (aOR 0.73, 95 % CI 0.64–0.85). Racial disparities in surgery recommendation and its
performance did not decrease from 1988 to 2009. In multivariable adjusted analyses, blacks refused surgery more often when it was
recommended (aOR in 1988 4.75, 95 % CI 2.51–9.01); this disparity decreased over time (aOR 0.93 per year, 95 % CI 0.89–0.97).
Conclusions Although racial disparities in pancreatic cancer surgery refusal have diminished over the past two decades,
significant disparities in the recommendation and performance of surgery persist. It is likely that both provider- and patient-
level factors have a substantial impact on surgery recommendation and its acceptance. The identification of such factors is critical
to design a framework for eliminating disparities in cancer-directed surgery for pancreatic cancer.
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Introduction
Pancreatic cancer is a common cause of cancer mortality in the
USA, with more than 40,000 estimated new cases in 2012.1
Blacks have a higher incidence of disease compared with
whites2 and experience poorer median survival.3 The reasons
for this differential survival are likely multifactorial, including
variations in treatment pattern based on socioeconomic status
and race. Employment, education, and poverty level are com-
mon measures of socioeconomic status and may portend
differential access to pancreatic cancer treatment.4
Racial differences have been observed in pancreatic cancer
treatment patterns. A recent 10-year analysis demonstrated
that black and white patients with pancreatic cancer were
recommended to undergo pancreatectomy at similar rates,5
though black patients refuse recommended surgical interven-
tion more often than whites.5
,6 Nevertheless, it is unknown
whether such racial disparities in pancreatic cancer treatment
have changed over time.
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Using the Surveillance, Epidemiology, and End Results
(SEER) registry from 1988 to 2009, we explored racial dispar-
ities in surgical resection for pancreatic cancer. Specifically, we
tested three hypotheses: (1) blacks with pancreatic cancer are
recommended surgical resection less often than whites; (2)
when recommended surgical resection, blacks refuse surgery
more often than whites; and lastly, (3) racial differences in
refusal of surgical resection have decreased over time.
Methods
An institutional review board approved this retrospective co-
hort study of the SEER cancer registry data from 1988 to
2009.7 Briefly, SEER is the largest population-based cancer
registry in the USA; it encompasses approximately 28 % of the
US population. SEER*Stat 7.0.5 (SEER, Bethesda, MD, USA)
was used to extract patient information. All patients aged
≥18 years with a malignant tumor of the pancreas were includ-
ed.We then excluded patients with nonadenocarcinoma tumors
which were identified using SEER ICD-O-3 histology codes:
8010 to 8012, 8015, 8020 to 8022, 8140/8141, 8143, 8147,
8210/8211, 8230/8231, 8260 to 8263, 8440, 8450, 8452/8453,
8470/8471, 8480/8481, 8490, 8503/8504, 8507/8508, 8510,
8514, 8521, 8560, 8562, and 8570 to 8576.8 Patients with race
other than white or black, including those with unknown race,
were excluded from the analyses as were patients with pancre-
atic cancer noted only on the autopsy/death certificate. Patients
with distant metastatic disease were also excluded as they are
not candidates for potentially curative tumor resection. All
other patients were considered to be potentially eligible for
surgery. Resection was defined using SEER pancreas codes
for cancer-directed surgery: 10 (local or partial surgical exci-
sion of pancreas), 20 (total pancreatectomy with/without sple-
nectomy), 30 (subtotal gastrectomy, duodenectomy with com-
plete or partial pancreatectomy with/without splenectomy
[Whipple’s operation]), 40 (radical regional [partial] pancrea-
tectomy with lymph node dissection and adjacent soft tissue
resection), 50 (pancreatectomy, NOS), and 90 (surgery, NOS).
The following patient characteristics were evaluated: age
(continuous), gender, race (white, black), marital status (mar-
ried, unmarried, unknown), year of diagnosis (grouped as
1988–1997, 1998–2003, 2004–2009 to achieve comparable
group size), primary tumor location (head of pancreas, other),
tumor T-stage (grouped: T0/1/2, T3, T4, TX), tumor N-stage
(N0, N1, NX), presence of multiple tumors (yes, no), tumor
resection performed (yes, no, unknown), reason why no cancer
resection was performed (refused, other), external beam radia-
tion therapy (EBRT) performed (yes, refused, none/other, un-
known), and cause of death (alive at last follow-up, pancreas,
other), as well as the following ecological variables (based on
census tract information): rural or urban location (rural, urban
population ≤250,000, urban population >250,000, unknown),
less than high school education (percentage), and percentage of
families below poverty. Tumor T-stage is available in SEER as
a distinct variable starting in 2002. Before then, tumor T-stage
is not directly available in SEER and was therefore manually
recoded using available SEER variables (“extent of disease”).
Because it was not possible to distinguish between T1 and T2
tumors, they were grouped together with T0 as one group. In
patients where neoadjuvant therapy or no tumor resection was
performed, tumor stage is based on clinical information; for
resected cancers, pathological tumor stage is noted.
The primary outcome was the difference in the proportion
of whites versus blacks refusing surgery among patients rec-
ommended for resection from 1988 to 2009. To assess this, we
identified all patients for whom surgery was recommended as
well as those who ultimately underwent surgery. We then
identified patients for whom surgery was recommended and
performed. Lastly, we identified patients who refused surgery
when it was recommended. In SEER, this is defined as “pa-
tient or patient’s guardian refused” surgery.2 This distinction is
possible using SEER as it provides detailed information re-
garding why no surgery was performed even though it was
recommended.
Statistical Analysis
Demographic and tumor-related characteristics were com-
pared between whites and blacks using Pearson’s Chi-square
test for unadjusted estimates among categorical variables
(counts, percentage) and two-sample unpaired t tests for con-
tinuous variables (mean, standard deviation). Univariate and
multivariable logistic regression analyses were performed in
order to identify predictors of the following: (1) recommen-
dation for surgery among patients potentially eligible for
surgery, (2) performance of surgery among patients potentially
eligible for surgery, (3) surgical resection among patients for
whom surgery was recommended, and (4) refusal of surgery
among patients for whom surgery was recommended. The
following variables were considered as potential confounders
for the four aforementioned outcomes: race, year of diagnosis,
age, gender, marital status, tumor localization, T-stage, N-stage,
presence of multiple tumors, radiotherapy, rural/urban location,
high school education, and families below poverty; the last three
variables are based on census tract information. These variables
were selected a priori and included in the multivariable adjusted
logistic regression analyses. To examine whether differences in
surgery refusal changed over time, an interaction term between
race (white, black) and year (continuous) was added to the
logistic regression model. The interaction term was only kept
in the final model if it was statistically significant.We performed
sensitivity analysis for the multivariable analysis, excluding
patients with T4 disease and of unknown tumor stage, to account
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for the fact that resectability in locally advanced pancreatic
cancer is still of great debate.
Results are presented as odds ratios (OR) with 95 % con-
fidence interval (CI). All statistical analyses were performed
using STATA/SE version 11.2 (Stata Corporation, College
Station, TX, USA).
Results
A total of 35,944 patients with nonmetastatic pancreatic can-
cer were included in this study (Fig. 1). Most subjects were
white (n=31,495, 87.6 %). Compared with blacks, white
patients were older, more often male and married, and more
frequently had a solitary tumor and one that was located in the
pancreatic head (Table 1).
Predictors of Surgery Being Recommended
Pancreatic cancer resection was less often recommended to
black (35.0 %) compared with white (39.4 %) patients (uOR
(unadjusted OR) 0.83, CI 0.82–0.95, p<0.001) (Table 2). This
finding retained statistical significance after adjustment for
several patient and tumor-related characteristics (aOR (adjust-
ed OR) 0.88, CI 0.82–0.95, p=0.001); this racial disparity did
not significantly change over time. In multivariable adjusted
analyses, surgery was less often recommended in 2009 com-
pared with 1988, as well as for patients with older age and
advanced tumor stage and from areas of higher family poverty.
In contrast, surgery was more often recommended to females,
married patients, those with lymph node involvement, those
with multiple tumors, and patients who refused EBRT.
Predictors of Surgery Being Performed
Among all patients, pancreatic cancer resection was less often
performed in black versus white patients (uOR 0.80, 95 % CI
0.74–0.86, p<0.001); this difference did not change over time
(Table 3). The significantly lower proportion of pancreatic
resections in blacks was still observed after multivariable
adjustment (aOR 0.83, CI 0.76–0.91, p<0.001). However,
the odds of surgery performed among all patients with a
potentially resectable pancreatic cancer increased from 1988
to 2009 (aOR per year 1.014, CI 1.009–1.020, p<0.001
[21.9 % from 1988 to 1997, 26.3 % from 1998 to 2003,
29.5 % from 2004 to 2009]); the interaction between race
and year was not significant. Pancreatic resection was more
often performed in patients with the following characteristics:
female, married, positive lymph nodes, multiple primary tu-
mors, underwent EBRT, and from areas with lower education-
al attainment. On the other hand, surgery was less often
performed in older patients, those with advanced tumor stage,
patients who refused EBRT, and those living in areas of higher
poverty.
Predictors of Surgical Resection Among Patients
Who Were Offered Surgery
Blacks less often underwent surgical resection of pancreatic
cancer compared with whites if surgery was recommended
(uOR 0.87, CI 0.78–0.97, p=0.01) (Table 4). While this dif-
ference was observed to significantly decrease over time in
unadjusted analyses (uOR per year 0.97, CI 0.95–0.99,
p=0.005), no difference was detected over time in covariate-
adjusted models. The number of resections among patients to
whom surgery was offered did increase from 1988 to 2009
(aOR per year 1.07, CI 1.06–1.08, p<0.001). Surgery was also
more frequently performed in patients to whom surgery was
offered if they were married, had a T3 tumor or lymph node-
positive disease, had multiple tumors, received EBRT, and
resided in areas with lower education levels. Conversely, sur-
gery was less often performed in those with older age, with T4
tumor stage, who refused EBRT, and who resided in an area
with higher poverty.
Predictors of Refusal Among Patients Recommended
for Surgical Resection
Among patients for whom surgery was recommended, 104
blacks (6.7 %) refused pancreatic cancer resection compared
with 588 whites (4.7 %) (uOR 1.44, CI 1.16–1.79, p=0.001)
(Table 5). This significant racial difference persisted in adjusted
analyses (aOR in 1988 4.75, CI 2.51–9.01, p<0.001) though
decreased over time with an aOR of 0.93 per year (CI 0.89–
0.97, p=0.001).Fig. 1 Study participant flow chart
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Table 1 Demographic character-
istics (n=35,944) overall and by
race
Overall Black
(n=4,449)
White
(n=31,495)
p value
Age (mean/SD) 69.8 (12.1) 66.9 (12.4) 70.2 (12.0) 0.003
Gender
Male 17,430 (48.5) 1,988 (44.7) 15,442 (49.0) <0.001
Female 18,514 (51.5) 2,461 (55.3) 16,053 (51.0)
Marital status
Married 19,828 (55.2) 1,682 (37.8) 18,146 (57.6) <0.001
Unmarried 15,050 (41.9) 2,584 (58.1) 12,466 (39.6)
Unknown 1,066 (3.0) 183 (4.1) 883 (2.8)
Tumor location
Pancreatic head 25,216 (70.2) 3,060 (68.8) 22,156 (70.3) 0.03
Other 10,728 (29.8) 1,389 (31.2) 9,339 (29.7)
T-stage
T0/1/2 8,259 (23.0) 1,014 (22.8) 7,245 (23.0) <0.001
T3 18,750 (52.2) 2,183 (49.1) 16,567 (52.6)
T4 7,279 (20.2) 1,012 (22.7) 6,267 (19.9)
Tx 1,656 (4.6) 240 (5.4) 1,416 (4.5)
N-stage
N0 17,612 (49.0) 2,309 (51.9) 15,303 (48.6) <0.001
N1 11,146 (31.0) 1,252 (28.1) 9,894 (31.4)
Nx 7,186 (20.0) 888 (20.0) 6,298 (20.0)
Multiple tumors
No 30,050 (83.6) 3,814 (85.7) 26,236 (83.3) <0.001
Yes 5,894 (16.4) 635 (14.3) 5,259 (16.7)
Year of diagnosis
1988–1997 8,545 (23.8) 1,079 (24.2) 7,466 (23.7) 0.72
1998–2003 11,677 (32.5) 1,440 (32.4) 10,237 (32.5)
2004–2009 15,722 (43.7) 1,930 (43.4) 13,792 (43.8)
Tumor resection performed
Yes 9,582 (26.7) 1,025 (23.0) 8,557 (27.2) <0.001
No 26,215 (72.9) 3,410 (76.7) 22,805 (72.4)
Unknown 147 (0.4) 14 (0.3) 133 (0.4)
Radiotherapy (external beam)
Yes 10,710 (29.8) 1,162 (26.1) 9,548 (30.3) <0.001
Refused 571 (1.6) 64 (1.4) 507 (1.6)
None/other 23,960 (66.7) 3,141 (70.6) 20,819 (66.1)
Unknown 703 (2.0) 82 (1.8) 621 (2.0)
Rural/urban
Rural 554 (1.5) 28 (0.6) 526 (1.7) <0.001
Urban≤250,000 12,871 (35.8) 1,198 (26.9) 11,673 (37.1)
Urban>250,000 22,517 (62.6) 3,223 (72.4) 19,294 (61.3)
Unknown 2 (0.0) 0 2 (0.0)
Education below high school (mean, SD) 20.6 (7.4) 23.0 (6.8) 20.3 (7.4) <0.001
Unknown 2 (0.0) 0 2 (0.0)
Families below poverty (mean, SD) 9.2 (4.8) 11.7 (4.9) 8.9 (4.7) <0.001
Unknown 2 (0.0) 0 2 (0.0)
Cause of death
Alive at last follow-up 4,256 (11.8) 496 (11.2) 3,760 (11.9) <0.001
Pancreatic cancer 27,768 (77.3) 3,334 (74.9) 24,434 (77.6)
Other 3,920 (10.9) 619 (13.9) 3,301 (10.5)
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Sensitivity Analysis Excluding T4 and TX Tumor Stage
All estimates comparing blacks and whites for (a) receipt of a
surgery recommendation, (b) surgery being performed, and (c)
surgery explicitly offered yet refused remained stable including
their significance levels in the main analysis (data not shown).
Discussion
Several national health-care organizations, such as the National
Cancer Institute and Agency for Healthcare Research and
Quality, have prioritized the identification and reduction of
health-care disparities.9
,10 Understanding the magnitude of
Table 2 Predictors of surgery
recommended among 35,944
patients with potentially resect-
able pancreatic cancer
Reference group: surgery being
recommended. In multivariable
adjusted analysis, adjustment was
performed for gender, marital sta-
tus, primary tumor localization,
T-stage, N-stage, presence of
multiple tumors, radiotherapy
performance, rural/urban loca-
tion, high school education, and
families below poverty
Surgery
recommended
(n=13,973)
Surgery not
recommended
(n=21,971)
Multivariable
adjusted
OR (95 % CI)
p value
Race
White 12,416 (39.4) 19,079 (60.6) Ref. 0.001
Black 1,557 (35.0) 2,892 (65.0) 0.88 (0.82–0.95)
Year of diagnosis 0.976 (0.972–0.981) <0.001
Interaction race × year n.s. n.s.
Age (mean, SD) 67.2 (11.8) 71.4 (11.9) 0.974 (0.972–0.976) <0.001
Gender
Male 6,900 (39.6) 10,530 (60.4) Ref. 0.003
Female 7,073 (38.2) 11,441 (61.8) 1.08 (1.02–1.13)
Marital status
Married 8,340 (42.1) 11,488 (57.9) 1.19 (1.13–1.25) <0.001
Unmarried 5,212 (34.6) 9,838 (65.4) Ref.
Unknown 421 (39.5) 645 (60.5)
Tumor localization
Head 10,124 (40.1) 15,092 (59.9) Ref. 0.95
Other 3,849 (35.9) 6,879 (64.1) 1.00 (0.95–1.05)
T-stage
T0/1/2 3,669 (44.4) 4,590 (55.6) Ref.
T3 8,535 (45.5) 10,215 (54.5) 0.90 (0.85–0.96) <0.001
T4 1,483 (20.4) 5,796 (79.6) 0.27 (0.25–0.29) <0.001
TX 286 (17.3) 1,370 (82.7) 0.32 (0.28–0.37) <0.001
N-stage
N0 6,139 (34.9) 11,473 (65.1) Ref.
N+ 6,145 (55.1) 5.001 (44.9) 2.12 (2.01–2.24) <0.001
Nx 1,689 (23.5) 5,497 (76.5) 0.58 (0.54–0.63) <0.001
Multiple tumors
Yes 2,325 (39.4) 3.569 (60.6) 1.14 (1.07–1.21) <0.001
No 11,648 (38.8) 18,402 (61.2) Ref.
Radiotherapy (beam)
Yes 4,754 (44.4) 5,956 (55.6) 1.00 (0.95–1.05) 0.98
Refused 253 (44.3) 318 (55.7) 1.46 (1.22–1.75) <0.001
No 8,685 (36.2) 15,275(63.8) Ref.
Unknown 281 (40.0) 422 (60.0)
Rural/urban
Rural 196 (35.4) 358 (64.6) Ref.
Urban≤250,000 5,239 (40.7) 7,632 (59.3) 1.13 (0.92–1.37) 0.24
Urban>250,000 8,537 (37.9) 13,980 (62.1) 0.94 (0.78–1.15) 0.57
Unknown 1 (50.0) 1 (50.0)
Education below high school (mean, SD) 20.3 (7.1) 20.8 (7.5) 0.995 (0.989–1.000) 0.06
Unknown 1 (50.0) 1 (50.0) Ref.
Families below poverty (mean, SD) 9.0 (4.7) 9.4 (4.8) 0.986 (0.977–0.994) 0.001
Unknown 1 (50.0) 1 (50.0)
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these disparities in pancreatic cancer surgery, especially their
trends, can inform efforts to improve health-care access for
select populations and aid in future research funding alloca-
tion. We therefore examined three specific hypotheses: wheth-
er blacks with pancreatic cancer are recommended surgical
resection less often than whites, blacks refuse surgery more
often than whites when recommended surgery, and finally,
that racial differences in refusal of surgical resection have
decreased over time. Our analysis of the SEER registry from
1988 to 2009 suggests that blacks with pancreatic cancer are
Table 3 Predictors of surgery
performed among all patients
with nonmetastatic pancreatic
cancer (n=35,797 patients)
Reference group: surgery being
performed. In multivariable
adjusted analysis, adjustment was
performed for gender, marital sta-
tus, primary tumor localization,
T-stage, N-stage, presence of
multiple tumors, radiotherapy
performance, rural/urban loca-
tion, high school education, and
families below poverty (147
patients with unknown informa-
tion if surgery was performed
(0.41 %))
Surgery
performed
(n=9,582)
Surgery not
performed
(n=26,215)
Multivariable
adjusted
OR (95 % CI)
p value
Race
White 8,557 (27.3) 22,805 (72.7) Ref. <0.001
Black 1,025 (23.1) 3,410 (76.9) 0.83 (0.76–0.91)
Year of diagnosis 1.014 (1.009–1.020) <0.001
Interaction race × year n.s. n.s.
Age 65.2 (11.3) 71.5 (11.9) 0.959 (0.957–0.962) <0.001
Gender
Male 4,870 (28.1) 12,486 (71.9) Ref. 0.005
Female 4,712 (25.6) 13,729 (74.4) 1.08 (1.02–1.15)
Marital status
Married 3,193 (21.3) 11,798 (78.7) 1.40 (1.32–1.48) <0.001
Unmarried 6,144 (31.1) 13,613 (68.9) Ref.
Unknown 245 (23.4) 804 (76.6)
Tumor location
Head 7,081 (28.2) 18,036 (71.8) Ref. 1.00
Other 2,501 (23.4) 8,179 (76.6) 1.00 (0.94–1.06)
T-stage
T0/1/2 2,455 (29.9) 5,756 (70.1) Ref.
T3 6,435 (34.4) 12,260 (65.6) 1.00 (0.93–1.06) 0.94
T4 582 (8.0) 6,671 (92.0) 0.15 (0.13–0.17) <0.001
Tx 110 (6.7) 1,528 (93.3) 0.18 (0.14–0.22) <0.001
N-stage
N0 4,156 (23.7) 13,373 (76.3) Ref.
N1 5,216 (46.9) 5,898 (53.1) 2.55 (2.41–2.70) <0.001
Nx 210 (2.9) 6,944 (97.1) 0.11 (0.09–0.13) <0.001
Multiple tumors
Yes 1,610 (27.4) 4,263 (73.4) 1.23 (1.15–1.33) <0.001
No 7,972 (26.6) 21,952 (72.6) Ref.
Radiotherapy (beam)
Yes 3,780 (23.1) 6,918 (76.9) 1.18 (1.11–1.25) <0.001
Refused 93 (16.3) 477 (83.7) 0.62 (0.48–0.80) <0.001
No 5,513 (23.1) 18,351 (76.9) Ref.
Unknown 196 (29.5) 469 (70.5)
Rural/urban
Rural 143 (26.5) 397 (73.5) Ref.
Urban≤250,000 3,457 (27.0) 9.347 (73.0) 0.92 (0.73–1.16) 0.47
Urban>250,000 5,982 (26.6) 16,469 (73.4) 0.89 (0.71–1.12) 0.32
Unknown 0 2 (100.0)
Education below high school (mean, SD) 20.4 (7.3) 20.7 (7.4) 1.011 (1.005–1.018) 0.001
Unknown 0 2 (100.0)
Families below poverty (mean, SD) 9.3 (4.8) 9.0 (4.7) 0.969 (0.959–0.979) <0.001
Unknown 0 2 (100.0)
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less likely to be recommended for surgery compared with
whites. Furthermore, surgery is less likely performed in blacks
including among patients to whom surgery is recommended.
These disparities did not significantly change over time. We
also found that even when surgery was recommended, blacks
refused surgical resection more often compared with whites,
though this disparity has decreased significantly over the past
two decades.
Table 4 Predictors of surgical
resection among patients who
were offered surgery (n=13,961)
Reference group: surgery being
performed. In multivariable
adjusted analysis, adjustment was
performed for gender, marital sta-
tus, primary tumor localization,
T-stage, N-stage, presence of
multiple tumors, radiotherapy
performance, rural/urban loca-
tion, high school education, and
families below poverty (12
patients with unknown informa-
tion if surgery was performed
(0.09 %))
Surgery
performed
(n=9,582)
Surgery not
performed
(n=4,379)
Multivariable
adjusted OR
(95 % CI)
p value
Race
White 8,557 (69.0) 3,848 (31.0) Ref. <0.001
Black 1,025 (65.9) 531 (34.1) 0.73 (0.64–0.85)
Year 1.07 (1.06–1.08) <0.001
Interaction race × year n.s. n.s.
Age 65.2 (11.3) 71.8 (11.7) 0.955 (0.951–0.959) <0.001
Gender
Male 4,870 (70.6) 2,027 (29.4) Ref. 0.48
Female 4,712 (66.7) 2,352 (33.3) 1.03 (0.94–1.14)
Marital status
Married 6,144 (73.7) 2,192 (26.3) 1.45 (1.32–1.60) <0.001
Unmarried 3,193 (61.3) 2,012 (38.7) Ref.
Unknown 245 (58.3) 175 (41.7)
Tumor location
Head 7,081 (70.0) 3,033 (30.0) Ref. 0.13
Other 2,501 (65.0) 1,346 (35.0) 1.08 (0.98–1.20)
T-stage
T0/1/2 2,455 (67.0) 1,208 (33.0) Ref.
T3 6,435 (75.4) 2,096 (24.6) 1.20 (1.08–1.33) 0.001
T4 582 (39.3) 900 (60.7) 0.33 (0.28–0.39) <0.001
Tx 110 (38.6) 175 (61.4) 0.27 (0.20–0.39) <0.001
N-stage
N0 4,156 (67.8) 1,974 (32.2) Ref.
N1 5,216 (84.9) 926 (15.1) 2.38 (2.16–2.63) <0.001
Nx 210 (12.4) 1,479 (87.6) 0.10 (0.08–0.11) <0.001
Multiple tumors
Yes 1,610 (69.3) 713 (30.7) 1.27 (1.12–1.43) <0.001
No 7,972 (68.5) 3,666 (31.5) Ref.
Radiotherapy (beam)
Yes 3,780 (79.5) 973 (20.5) 1.31 (1.18–1.45) <0.001
Refused 93 (36.8) 160 (63.2) 0.29 (0.21–0.39) <0.001
No 5,513 (63.6) 3,162 (36.4) Ref.
Unknown 196 (70.0) 84 (30.0)
Rural/urban
Rural 143 (73.0) 53 (27.0) Ref.
Urban≤250,000 3,457 (66.0) 1,779 (34.0) 0.80 (0.53–1.21) 0.30
Urban>250,000 5,982 (70.1) 2,546 (29.9) 0.94 (0.62–1.42) 0.77
Unknown 0 1 (100.0)
Education below high school (mean, SD) 20.4 (7.3) 20.0 (6.8) 1.037 (1.026–1.049) <0.001
Unknown 0 1 (100.0)
Families below poverty
(mean, SD)
9.0 (4.7) 9.0 (4.8) 0.960 (0.945–0.976) <0.001
Unknown 0 1 (100.0)
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This study adds to and updates the findings of Murphy and
colleagues who previously examined racial disparities in pan-
creatic cancer resection using SEER registry data from 1992 to
2002.5 The authors concluded that, although blacks and whites
presented with similar disease stage and were similarly recom-
mended for resection, blacks were significantly more likely
to refuse recommended surgery.5 Our analysis differs from
Murphy in that we examined a longer time interval to evaluate
longitudinal trends in recommendation and acceptance of sur-
gery, we focused on the ethical comparison of whites and
blacks, we excluded patients with distant metastasis as those
patients are still not considered candidates for surgical resec-
tion, and we included ecological variables to the multivariable
analyses to adjust for such differences between whites and
Table 5 Predictors of refusal
among patients recommended for
surgical resection (n=13,961)
Reference group: surgery not
refused. In multivariable adjusted
analysis, adjustment was
performed for gender, marital sta-
tus, primary tumor localization,
T-stage, N-stage, presence of
multiple tumors, radiotherapy
performance, rural/urban loca-
tion, high school education, and
families below poverty
Surgery not
refused
(n=13,269)
Surgery
refused
(n=692)
Multivariable
adjusted OR
(95 % CI)
p value
Race
White 11,817 (95.3) 588 (4.7) Ref. <0.001
Black 1,452 (93.3) 104 (6.7) 4.75 (2.51–9.01)
Year of diagnosis 1.05 (1.03–1.08) <0.001
Interaction between race × year 0.93 (0.89–0.97) 0.001
Age 66.8 (11.7) 76.3 (10.4) 1.07 (1.06–1.08) <0.001
Gender
Male 6,620 (96.0) 277 (4.0) Ref. 0.68
Female 6,649 (94.1) 415 (5.9) 0.96 (0.80–1.16)
Marital status
Married 8,055 (96.6) 281 (3.4) 0.71 (0.59–0.86) <0.001
Unmarried 4,818 (92.6) 387 (7.4) Ref.
Unknown 396 (94.3) 24 (5.7)
Tumor location
Head 9.606 (95.0) 508 (5.0) Ref. <0.001
Other 3,663 (95.2) 184 (4.8) 0.68 (0.55–0.83)
T-stage
T1/2 3,400 (92.8) 263 (7.2) Ref.
T3 8,237 (96.6) 294 (3.5) 0.59 (0.49–0.72) <0.001
T4 1,413 (95.3) 69 (4.7) 0.64 (0.47–0.87) 0.004
Tx 219 (76.8) 66 (23.2) 2.38 (1.63–3.47) <0.001
N-stage
N0 5,698 (93.0) 432 (7.0) Ref.
N1 6,069 (98.8) 73 (1.2) 0.21 (0.16–0.28) <0.001
Nx 1,502 (88.9) 187 (11.1) 1.67 (1.33–2.10) <0.001
Radiotherapy (beam)
Yes 4,669 (98.2) 84 (1.8) 0.64 (0.50–0.82) <0.001
Refused 127 (50.2) 126 (49.8) 22.7 (16.4–31.3) <0.001
No 8,201 (94.5) 474 (5.5) Ref.
Unknown 272 (97.1) 8 (2.9)
Rural/urban
Rural 180 (91.8) 16 (8.2) Ref.
Urban≤250,000 4,983 (95.2) 253 (4.8) 0.77 (0.40–1.50) 0.45
Urban>250,000 8,105 (95.0) 423 (5.0) 0.87 (0.45–1.68) 0.68
Unknown 1 (100.0) 0
Education below high school (mean, SD) 20.2 (7.1) 21.4 (7.7) 1.03 (1.01–1.05) 0.005
Unknown 1 (100.0) 0
Families below poverty (mean, SD) 8.9 (4.7) 9.7 (4.8) 0.99 (0.96–1.02) 0.47
Unknown 1 (100.0) 0
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blacks. In our study, both univariate and multivariate analyses
demonstrated racial disparities in the provision of a recommen-
dation for surgery as well as its acceptance.
Notably, we found that blacks were less likely to be rec-
ommended for pancreatic cancer surgery, suggesting that
provider-level factors may influence whether surgery is rec-
ommended. Bilimoria et al. found that, compared with white
patients, blacks encounter longer wait times between the
diagnosis of pancreatic cancer and surgery.11 Although the
reasons for such disparities are unclear, a physician’s thinking
and behavior may be unconsciously influenced by prejudice
depending on patient race.12 For example, black patients may
be less likely to receive needed cancer information and less
likely to receive the name of a cancer specialist.13 Lastly,
evidence from the orthopedic literature suggests that a pro-
vider’s decision whether to recommend surgery to black pa-
tients may depend on the patient’s baseline preference or
attitude regarding surgery.14
Our results support previous evidence that blacks are
more likely to refuse pancreatic cancer-directed surgery.15
Specifically, we found that blacks refused recommended pan-
creatic cancer resection more often than whites, though this
disparity decreased significantly over the past two decades. In
a recent study of curative surgery for upper gastrointestinal
cancers, black race was a predictor of nonsurgical approach.16
Interestingly, our results demonstrate that patients who refused
surgery were also more likely to refuse EBRT. There are
several patient-level reasons that could explain the refusal
of recommended surgery. Blacks historically have often
expressed distrust for the health-care system.17
,18 Black
patients often rate their physician visits as less participatory
compared with whites; visits with a provider of the same race
are rated as being more participatory.19 Lastly, it is unknown
whether preexisting factors prior to a patient’s evaluation for
pancreatic cancer may impact their decision making. In a
study of patient’s decisions regarding surgery for early stage
lung cancer, Cykert and colleagues found that a lack of regular
care and comorbid illness among blacks was associated with a
decision to defer surgery.20
Several observations in our analysis are worth noting.
While metastatic disease was excluded from our analysis,
we included T4 disease (i.e., that which has extended be-
yond the pancreas into nearby vasculature and nerves) which
is widely considered unresectable. Although this accounts
for nearly 20 % of our study population and potentially
skews the cohort of patients who were “recommended sur-
gery” as being appropriate, it is worth noting that surgery
was recommended in 20 % of these patients suggesting that
surgeons may be offering surgery where it is potentially not
appropriate and not offering it when it is appropriate (in our
sample, surgery was not recommended in 58 % with T0/1/2
disease). Without comorbidity data and information about
actual performance status in SEER, it is entirely possible that
surgeons are in fact making appropriate recommendations to
T4 and T1/2 patients, respectively. Relatedly, in order to
account for the possibility that the large proportion of pa-
tients with T4 or TX disease mainly influenced the result of
our study, we performed a sensitivity analysis excluding
these patients: there were no significant changes to our
conclusions.
Although we examined a large, representative cancer reg-
istry spanning 22 years, several limitations of our study are
acknowledged. Despite including nearly 36,000 patients in
our study, only 104 blacks and 588 whites refused surgery in
our study. Race is often a proxy for other explanatory demo-
graphic variables, such as education, socioeconomic status,
and marital status.21 Although our analyses are adjusted for
rural or urban residence, education level, and poverty level,
these data in SEER are based on ZIP code and census tract
data; prior studies have demonstrated the validity of census
tract measures as an approximation for individual socioeco-
nomic status (SES).22 Information on medical comorbidities,
which is not available in SEER, potentially influences a phy-
sician’s decision to recommend surgery as well as a patient’s
decision whether or not to accept recommended treatment.20
Data regarding individual hospitals and providers were not
available, precluding our ability to examine provider-specific
trends. One explanation for the observed racial disparities in
the present study is that black patients potentially cluster
among physicians, such as primary care physicians, who
may not refer to surgeons or have preconceived notions about
the treatment of pancreatic cancer. Lastly, detailed information
about the resectability of locally advanced pancreatic cancer is
also not available in SEER. It is therefore impossible to further
distinguish patients with locally advanced but still potentially
resectable disease from patients with locally unresectable
tumor burden. In light of the limitations presented, a national
dataset consisting of a large cohort of patients undergoing
pancreatic surgery is needed to identify subtle issues as
discussed in this manuscript; more information about patient
and provider characteristics would be desired.
Our analyses suggest that although racial disparities in the
refusal of pancreatic cancer surgery have diminished over the
past two decades, significant disparities in the recommenda-
tion and performance of surgery persist. Providers must strive
to minimize potential racial biases in their treatment recom-
mendations and attempt to better understand their patients’
reasons for refusing surgery. It is unclear why blacks continue
to be recommended surgical resection for pancreatic cancer
less often than whites. While it is encouraging that the racial
disparity in the refusal of pancreatic cancer surgery has de-
creased, it is likely that both provider- and patient-level factors
have a substantial impact on surgery recommendation and its
acceptance. The identification of such factors is critical to design
a framework for eliminating disparities in cancer-directed sur-
gery for pancreatic cancer.
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